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Abstract
Non-thermal plasmas (NTPs) are known for their ability to induce thermal-free cytotoxic effects on cancer
cells. However, as the variety of NTP devices increases, comparison of their cytotoxic effect becomes increasingly
essential. In this work, we compare the cytotoxicity of three different radio-frequency NTPs. MDA-MB-231 triple
negative breast cancer cells are treated in suspension in DMEM culture medium by the eﬄuents of a single radio-
frequency (RF) discharge device operating in three modes, namely the Ω and γ modes of the capacitively coupled
radio-frequency (CCRF) discharge and a RF plasma jet mode. All three discharge modes reduce the proliferative
capacity of MDA-MB-231 cells, but the treatment time required to reach the same efficacy is more than ten times
longer using the Ω and the γ modes than using the jet mode. In all cases, using the appropriate treatment time,
cells exhibit an impaired proliferation and eventually start to show signs of cell death (about 48 h after treatment).
The three discharge modes also induce nuclear DNA damages. Plasma-produced H2O2 was not found to contribute
to the cytotoxicity of the treatment. Furthermore, short-lived reactive species (gas phase or liquid phase species
with a lifetime below 1 s) are expected to play a dominant role over the long-lived reactive species in the anti-cancer
effect of all three discharge modes.
Index Terms: Non-thermal plasma, plasma oncology, triple negative breast cancer, plasma jet, radio-frequency
discharge, MDA-MB-231, suspension, DNA damages, proliferation.
1 Introduction
Application of non-thermal plasmas (NTP) to cancer
treatment has become an effervescent field during the
last two decades [1]. From in vitro fundamental research
to early clinical trials, suggestions of the potential use of
NTP as a new cancer treatment are numerous [2]. How-
ever, with a wide array of NTP sources and biological
assays evaluating multiple cancer models, it is difficult
to draw a uniform picture of the effect of NTP on cancer
cells, even in vitro [3]. On the NTP side alone, the diver-
sity is remarkable. For instance, non-thermal plasma jets
can be sustained using multiple plasma forming gases,
excitation frequencies (or waveforms) and electrode con-
figurations [4], without having taken into account dielec-
tric barrier discharges (DBDs) and other devices that are
also used in plasma medicine [5]. On the biological side,
the type of cancer and in vitro model used for plasma
experiments are numerous, resulting in great variations
in outcomes [6, 7]. In order to compare the cancer treat-
ment capability of different NTPs while keeping variabil-
ity to a minimum, biological parameters should be fixed
and controlled as much as possible [3, 8].
In this work, a convertible radio-frequency field ap-
plicator was designed to generate three NTPs of differ-
ent physical properties. In section 2, the convertible
plasma jet device is described while in section 3 some
basic plasma diagnostics are performed. Application of
the convertible plasma jet device to the treatment of
triple negative breast cancer cell line MDA-MB-231 is
presented in section 4. The results are then discussed
with respect to the different discharge modes in section
5.
2 Experimental methods
2.1 Plasma jet and diagnostics
2.1.1 Mechanical design of the field applicator
The electrode configuration of the convertible plasma jet
device is a coaxial configuration in which a dielectric
material separates the ground electrode and the annular
open gap for the flowing gas. The electrode configura-
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tion is shown in Fig. 1(a), where the ground electrode
consists of a stainless steel tube (4 mm and 6 mm of inner
and outer diameters, respectively) and the high-voltage
electrode consists of a smaller diameter stainless steel
tube (0.686 mm and 1.067 mm of inner and outer diam-
eters, respectively). A quartz tube (3 mm and 4 mm of
inner and outer diameters, respectively) acts as the di-
electric barrier (εr = 3.75), placed directly inside the
grounded tube, thus leaving an annular gap for gas in-
jection between the dielectric and the central powered
tube electrode. The whole assembly forms a dielectric
barrier discharge (DBD) configuration of 3 cm in length.
As the high-voltage electrode is hollow [9], the plasma-
forming gas can be injected either through it or through
the annular gap.
Figure 1: (a) Electrode configuration inside the field
applicator (front view) and simplified electrical circuit
showing the current and voltage measurements. (b)
Sketch of the convertible plasma jet device during a treat-
ment of cells in suspension in culture medium inside a
microtube (jet mode).
2.1.2 Electrical design of the field applicator
In the electrical circuit of Fig. 1(a), the central electrode
is connected to a 13.56 MHz RF power supply (Cesar
model 1312) via a matching network (Navio 57020137-
00D) and the external electrode is connected to the
ground. The instantaneous current and voltage are mea-
sured with a current transformer (Pearson 2877) placed
around the grounded electrode wire and a high-voltage
probe (Tektronix P6015) placed on the high-voltage elec-
trode, respectively. The electrical measurements are
recorded via a 100 MHz bandwidth digital oscilloscope
(Tektronix TDS2014C). Using current and voltage mea-
surements, the plasma power density is estimated to vary
in the 1 W cm−3 to 100 W cm−3 range, according to the
discharge mode.
2.1.3 Control of the discharge modes
Using the electrode assembly of Fig. 1, it is pos-
sible to sustain three different discharge modes when
a 13.56 MHz sinusoidal excitation waveform is fed to
the high-voltage electrode. These discharge modes, de-
scribed in section 3, are controlled using two parameters:
1. the applied power and
2. where the plasma-forming gas is injected.
In this work, all experiments are performed at at-
mospheric pressure (101.3 kPa) with helium (Praxair,
99.999% purity) injected either within the annular gas
gap between the dielectric and the hollow high-voltage
electrode or through the high-voltage electrode itself.
2.1.4 Basic plasma diagnostics
The optical emission of the discharge was collected by
an optical fibre for emission spectroscopy, and directly
with a camera for imaging. Optical emission spectra are
sampled in the electrode area and collected with the tip
of an optical fibre (600 µm core diameter) pointing di-
rectly toward the plasma. The optical fibre is connected
to a spectrometer system (200 nm to 850 nm) through a
100 µm slit (Ocean Optics, Flame-S equipped with a Sony
ILX-511B detector and a 600 line/mm grating). The op-
tical emission spectroscopy system was corrected by its
complete response curve using a Princeton Instruments
Intellical lamp above 400 nm and a 900 W Tungsten lamp
below. Pictures of the discharge are recorded with a CCD
camera (Nikon D40). The camera is positioned either in
front of the nozzle to collect the light coming from the
electrode area or perpendicularly to the nozzle to collect
the light emission produced outside of the nozzle. Fi-
nally, to determine the temperature within the treatment
zone, a grounded thermocouple (Omega, TJFT72-K-SS-
116G) was used.
2.2 Treatment method and biological di-
agnostics
To investigate the cytotoxicity of the different discharge
modes produced by the convertible plasma jet device, the
triple negative (estrogen receptor, progesterone receptor
and HER2 negative) breast cancer cell line MDA-MB-
231 is exposed to plasma and then analyzed with various
assays.
2.2.1 Cell culture and NTP treatment
Human breast cancer cell line MDA-MB-231, genetically
modified to express H2B-GFP (described elsewhere [10])
was used in this work. The cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) containing
10% foetal bovine serum and 1% penicillin streptomycin
in a humidified atmosphere at 5% CO2 and 37 ◦C. A
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cell suspension was prepared and a total of 1× 104 cells
together with 400 µL of medium were distributed in non-
adherent 1.5 mL microtubes (Eppendorf). In this work,
the plasma treatment is performed directly within the
microtubes (see [Fig. 1(b)]). Hence, the cells are treated
in suspension rather than attached to the bottom of a
petri dish. To perform the treatments, the nozzle of
the plasma applicator is positioned inside the microtube,
about 5 mm above the surface of the medium. As shown
in Fig. 1(b), the visible plasma jet was not in contact
with the medium. Treatments were performed with the
different discharge modes using an applied power of 0 W
to 35 W at the generator and a gas flow of 0.6 L min−1 to
4.3 L min−1, for a duration of 5 s to 300 s. After plasma
treatment, cells were collected and seeded in multi-well
plates for either proliferation or cell death assays, or pre-
pared a for a DNA damage assay. The same plasma
conditions and procedures were used to produce plasma
treated medium (PTM), but in this case, cells are not
present in the microtube during the treatment but are
rather seeded in the multi-well plate after collecting PTM
from the microtube.
2.2.2 Proliferation assay
Approximately within 1 h after plasma treatment, cells
were seeded into 24-well plates and allowed to recover
and proliferate over a period of 6 d. During this prolifer-
ation period, cells were maintained in 500 µL of medium
per well. Only 20% of this medium was carried from
the treated microtube. Subsequently, the recovered cells
were fixed and stained in 10% methanol solution con-
taining 0.5% Crystal Violet. Staining with CellTag 700
(LI-COR) allows quantification using the Odyssey imag-
ing system (LI-COR Biotechnology).
2.2.3 Cell death measurement by propidium io-
dide uptake
Approximately within 1 h after plasma treatment, cells
were seeded into multi-well plates and 1 µg mL−1 of pro-
pidium iodide (PI) were added to each well. Cells were
allowed to recover and proliferate over a time period
of 6 d, while being monitored by live-cell fluorescence
microscopy (IncuCyte S3 Live-Cell Analysis System).
Frames were captured at 4 h intervals using a 10x objec-
tive. The percentage of PI-positive cells was calculated
from the number of PI-positive cells on the total number
of cells (via the count of H2B-GFP positive nuclei) using
the IncuCyteTM S3 software. During the incubation pe-
riod, cells were maintained in 500 µL of medium per well.
Only 20% of this medium was carried from the treated
microtube.
2.2.4 DNA damage assay
DNA damages (mostly double strand breaks) are inves-
tigated using the neutral single cell gel electrophore-
sis assay (comet assay). The neutral comet assay
was performed according to the manufacturer’s protocol
and reagent kit (Trevigen, 4250-050-K). In brief, after
plasma treatment, cells were resuspended in phosphate-
buffered saline (PBS) and mixed with low melting point
agarose. The cell-containing agarose was then pipetted
onto microscope slides and incubated with a lysis buffer
overnight at 4 ◦C. The next day, the slides were re-
moved from the lysis buffer and immersed in neutral elec-
trophoresis buffer. Electrophoresis was then performed
at 21 V, during 25 min. After ethanol cleaning and dry-
ing of the slides, staining with SYTOX Green Nucleic
Acid Stain (Invitrogen) was performed. Images were ac-
quired by fluorescence microscopy (Zeiss, AxioObserver
Z1) with a 10x objective using the AxioVision (Zeiss)
software. The percentage of DNA in the tail and the
tail moment were obtained using the OpenComet Im-
ageJ plugin [11]. Positive control for DNA damages were
obtained by treating the cells with radiation therapy.
Cell suspensions were exposed to 8 Gy of γ irradiation
with the help of a Caesium-137 source (Best Theratron-
ics, Gammacell 3000 Elan), using the same vessel and
preparation method as for the plasma treatment.
2.2.5 H2O2 and pH quantification
The production of H2O2 by the interaction of the plasma
eﬄuent with DMEM was investigated using the PierceTM
Quantitative Peroxide Assay Kit, Aqueous-Compatible
Formulation (Thermo Scientific). Additionally, pH vari-
ations of the culture medium after exposure to plasma
were measured using a pH meter (FiveEasy F20-Std-Kit,
Mettler Toledo). For these measurements, DMEM cul-
ture medium microtubes were prepared and treated us-
ing the same procedure as for the proliferation assay. No
cell suspension was present during the treatments. H2O2
and pH were then obtained following the manufacturer’s
instructions.
3 Characterization of the dis-
charge modes
In order to determine the influence of plasma on cancer
cells, some basic plasma properties are first investigated.
The nature of the discharge is identified with the help of
spectrally integrated light emission, and the plasma and
electron energy are investigated with the help of emission
spectroscopy.
3.1 Discharge modes
In order to observe the different discharge modes, the
light distribution between the electrodes is measured
with the help of a CCD camera. Discharge pictures are
shown in Fig. 2(a) to (c), where the distribution of light
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emission is superimposed on a sketch of the electrodes
and dielectric.
Figure 2: Three discharge modes sustainable using the
convertible plasma jet. (a) to (c) Digital photograph of
the cross section (front view), showing the light distri-
bution between the electrodes superimposed on a sketch
of the electrodes and dielectric. (d) to (f) Digital photo-
graph of the light emission exiting the nozzle (side view).
(g) to (i) Sketch of the light emission inside and outside
the nozzle showing the last 3 mm of the nozzle. The CCD
exposure is 67 ms in (a), 2.5 ms in (b) and (c) and 769 ms
in (d),(e) and (f).
In Fig. 2(a), helium is flowing at a rate of 4.3 L min−1
in the annular region between the dielectric and the high-
voltage electrode. No gas is injected through the high-
voltage tube electrode, but a previous helium purge and
the surrounding helium flow prevent air from accessing
this region. The power applied at the generator is 10 W.
Based on electrical measurements, the plasma power den-
sity is estimated at ∼ 7 W cm−3 (assuming a discharge
volume defined by the annular gap and the length of the
ground electrode). At such a reduced power, the light
intensity is relatively low and uniform between the elec-
trodes (in the radial direction). This is typical of an at-
mospheric pressure RF discharge with a gas gap of about
1 mm [12]. This discharge mode is usually referred to as
the Ω mode (sometimes α mode) [13, 14].
In Fig. 2(b), helium is flowing at a rate of 4.3 L min−1
in the annular gap (exactly as for the Ω mode) but a
power of 20 W is applied at the generator. Based on
electrical measurements, the plasma power density is es-
timated at ∼ 23 W cm−3 (assuming a discharge volume
defined by the annular gap and the length of the ground
electrode). In this case, the light intensity distribution is
non-uniform between the dielectric barrier and the high-
voltage electrode (in the radial direction), with hot spots
localized on the high-voltage electrode. Near the high-
voltage electrode, the light intensity can be one order of
magnitude higher than in the bulk of the discharge. In
fact, this behaviour is typical of RF discharge at atmo-
spheric pressure in the γ mode [13, 15]. In the present sit-
uation, the facts that only one dielectric barrier is present
between the electrodes (on the ground electrode) [16]
and that the radius of the high-voltage electrode is small
(slight deviation from the uniform electric field produced
in plane-to-plane configuration) favour the discharge in
the γ mode to exhibit hot spots on the high-voltage elec-
trode.
In Fig. 2(c), helium is flowing at a rate of 0.6 L min−1
through the high-voltage electrode and a power of 35 W
is applied at the generator. No helium is injected in the
annular gap, thus allowing air to fill this space. Con-
sequently, as a helium channel is streaming out of the
nozzle, a plasma is ignited in the region located at the
tip of the high-voltage electrode. Due to the breakdown
voltage that is much higher in air than in helium [17], no
plasma is ignited in the annular gap. This results in a
plasma that is completely different from the previously
reported Ω and γ modes. Contrary to the Ω and γ mode,
the plasma itself is allowed to exit the nozzle (see [Fig.
2(f)]) and is therefore referred to as the jet mode. Cur-
rent and voltage measurements could not be performed
on this mode, but based on radiometric comparison to
the Ω and γ modes, the plasma power density is esti-
mated in the order of 100 W cm−3 (assuming a discharge
volume defined by the inner diameter of the high-voltage
electrode and the length of the visible emission).
Even if these three discharge modes are all generated
by an electric field oscillating at 13.56 MHz, the nature
of the discharge and its geometry leads to very different
schemes with respect to the potential application to liv-
ing tissues. In fact, these discharge modes lead to a very
different situation for a biological target located a few
millimetres away from the exit nozzle.
1. In the Ω mode [Fig. 2(d)], no visible emission is ob-
served. This suggests that only non-emitting long-
lived gas phase species (such as O, O2(a
1∆g), O3
N2O, etc.) can interact with the biological target.
The treatment then necessarily occurs in the plasma
eﬄuent [18, 19].
2. In the γ mode [Fig. 2(e)], a visible flowing afterglow
[20] is found at the exit of the nozzle. In such a
situation, only a limited number of electrons, ions,
and other short-lived species [21, 22] are present in
the interaction zone with the biological target. The
treatment could then occur within the flowing after-
glow or in the plasma eﬄuent.
3. In the jet mode [Fig. 2(f)], as supported by the in-
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tense light emission, the plasma itself exits the noz-
zle. In this case, all the components of the plasma
(electric field, charged particles, reactive species) are
allowed to interact with the biological target. The
treatment could then occur within the plasma itself
or in its eﬄuent [23].
Let us note that in this work, the treatment of cancer
cells always occurs in the eﬄuent, as neither the cells nor
the culture medium containing the cell suspension is in
visible contact with the plasma or the flowing afterglow.
Fig. 2(g) to (i) illustrate sketches of the plasma at the
end of the nozzle (the last 3 mm of the nozzle). From
these sketches, it is clear that in the Ω mode the plasma
is confined in the annular region between the dielectric
and the high-voltage electrode. However, in the jet mode,
the plasma is not ignited in the same region and expands
outside the nozzle, allowing it to interact with the biolog-
ical target. With its flowing afterglow, the γ mode lies
somewhere in between, as most of the plasma power den-
sity is consumed within the annular gap, but the plasma
excitation zone is slightly extended outside of the noz-
zle. The treatment area is also highly dependent on the
discharge mode as the diameter of the plasma-forming
region is up to 7.1 mm2 in the Ω and γ modes, while it is
of maximum 0.8 mm2 in the jet mode. For the remaining
of this work, the applied power, helium flow, and gas in-
jection configuration are fixed for each discharge mode.
This is summarized in table 1.
Ω mode γ mode Jet mode
Gas (gr. electrode) He flow He flow Ambient air
Gas (HV electrode) He He He flow
He flow (L/min) 4.3 4.3 0.6
Applied power (W) 10 20 35
Table 1: Summary of the experimental parameters fixed
in this work so that the three discharge modes can be
compared. In the Ω and the γ modes, the helium in the
high-voltage electrode is assumed to be confined within
the electrode but no flow is applied.
3.2 Optical emission spectroscopy
In order to compare the discharge modes, optical emis-
sion spectra are recorded. This is performed by placing
the tip of the optical fibre 1 cm away in front of the noz-
zle (i.e. in the invisible eﬄuent zone for all discharge
modes). In this manner, the recorded light emission is
integrated over the complete gas flow axis and represents
the plasma emission itself in any discharge mode.
Fig. 3(a) displays the spectrum of the Ω mode for
which the dominant emission is the OH(A2Σ+→X2Π)
(band head near 306 nm) molecular band often present
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Figure 3: Optical emission spectroscopy of the different
discharge modes. The light emission is integrated over
the complete plasma volume. The discharge is in (a)
the Ω mode (exposure 90 ms), (b) the γ mode (exposure
3 ms), and (c) the jet mode (exposure 15 ms).
in non-thermal atmospheric pressure discharge in con-
tact with humid air environment [24, 25]. Other op-
tical emission features typically present in atmospheric
pressure helium plasma in contact with ambient air
are the O(3 5P→3 5S) (centre wavelength at 777.5 nm)
and the H(3 2P→2 2S) (centre wavelength at 656.2 nm)
atomic lines. The He(3 3S→2 3P) (centre wavelength at
706.5 nm) atomic line is also an important emission, but
other helium lines are barely visible. Overall, this spec-
trum is typical of non-thermal atmospheric-pressure he-
lium discharges with traces of ambient air [25]. In Fig.
3(b), the spectrum of the γ mode is shown. In this case,
the same emission species are present in the spectrum
but the He (706.5 nm) becomes dominant over the trace
impurities. Other typical helium lines of non-thermal
atmospheric-pressure helium discharge becomes clearly
visible, namely the He(3 3D→2 3P) (centre wavelength
at 587.6 nm), the He(3 1D→2 1P) (centre wavelength at
667.8 nm) and the He(3 1S→2 1P) (centre wavelength at
728.1 nm). The overall intensity of the emissions in the
γ mode compared to the Ω mode is in good agreement
with the higher power density of the plasma, indicat-
ing that the electron energy and density are higher in
the γ mode [26]. At last, Fig. 3(c) shows the spectrum
of the jet mode. In this mode, as helium is only flow-
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ing in the high-voltage electrode and ambient air fills
the annular space between the dielectric barrier and the
high-voltage electrode, the plasma is surrounded by air.
Hence, mixing with ambient air is much more impor-
tant in the jet mode than in other modes. As a conse-
quence, nitrogen molecular bands are much more intense.
In fact, N2(C
2Πu→B3Πg) (second positive system) and
N +2 (B
2Σ +u →X2Σ +g ) (first negative system) become the
dominant emissions.
As the plasma volume and amount of ambient air
mixing changes significantly according to the discharge
mode, absolute emission intensity is not a suitable pa-
rameter to compare the discharge modes. To mitigate the
dissimilarities between the discharge modes, line ratios
can be considered. In non-thermal atmospheric-pressure
helium discharges, He(3 3D→2 3P)/He(3 3S→2 3P) and
He(3 1D→2 1P)/He(3 1S→2 1P) are considered to be
good indicators of electron energy [27]. To investigate
how the discharge mode affects the electron energy and
eventually the reactive species production, helium line
ratios are displayed in table 2.
Ω mode γ mode Jet mode
He(3 3D→2 3P)
He(3 3S→2 3P) 0.03 0.10 0.15
He(3 1D→2 1P)
He(3 1S→2 1P) 0.6 1.6 2.0
Table 2: Helium line ratios as an indicator of the elec-
tron energy in non-thermal atmospheric-pressure helium
discharges.
From table 2, it is clear that both ratios increase from
the Ω, to the γ and to the jet mode, which suggests that
the electron energy also increases. In terms of plasma
chemistry, higher electron energy can be interpreted as
more electrons possessing enough energy to produce a
given chemical reaction. Let us note that the helium
line ratios (and the electron energy) also vary slightly
as a function of the plasma power within the γ and jet
modes.
4 Cancer cells response to plasma
Using the three modes described in section 3, the poten-
tial anti-cancer effect of plasma is evaluated using differ-
ent biological assays.
4.1 Cell proliferation after plasma expo-
sure
It is expected that an efficient anti-cancer treatment
should lead to the death of cancer cells. However, ow-
ing to the variety of cell death and appropriate biolog-
ical markers to assess and classify it [28], it is usually
recognized that the best way to quantify the cytotoxic
effect of a treatment is based on the ability of the cells
to proliferate after the treatment [29]. The proliferative
capacity of the cells is shown in Fig. 4, where the cells
were allowed to grow for 6 d after plasma exposure using
different treatment times and discharge modes.
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Figure 4: Cell proliferation 6 d after plasma treatment.
Different treatment times are presented for each mode
(1 min, 2 min, 3 min, 4 min and 5 min for the Ω mode,
60 s, 90 s, 120 s, 150 s and 180 s for the γ mode and 5 s,
10 s, 15 s, 20 s and 25 s for the jet mode). (a) Example
image of MDA-MB-231 culture stained with CellTag 700
for treatments in the Ω mode (all cells are marked in
red). (b) Cell number (normalized to the control) as
a function of exposure to plasma. Error bars represent
the standard deviation on at least n = 3 independent
experiments. Statistical significance given by t-test with
*= p < 0.05 and **= p < 0.01.
Fig. 4(a) shows representative images of the normal-
ized MDA-MB-231 cancer cell number 6 d after treat-
ment in the Ω mode. It is clear that untreated and gas
flow treated cells (labelled as control and gas control)
were able to colonize the well almost up to full confluence.
However, as the duration of plasma treatment increases,
the proliferative capacity of the cells decreases drasti-
cally. In Fig. 4(b), the number of cells normalized to the
control as a function of treatment time is shown for the
three discharge modes. After the proliferation period of
6 d, all three discharge modes can reduce the number of
cells below 20% in comparison to the control. Even if this
reduction of proliferation can reach the same level with
all three discharge modes, the Ω mode requires longer
treatment time than the γ mode, and much longer than
the jet mode. With the jet mode, treatment time can be
as low as 10 s, while in the Ω mode, several minutes are
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required to reach a similar anti-proliferative effect.
4.2 Cell death dynamics
Even if the anti-proliferative capacity of plasma treat-
ments could be assessed in section 4.1, results of Fig. 4
do not allow the investigation of the fate of individual
cells after plasma exposure. To do so, cells are marked
with PI after plasma treatment and then followed us-
ing live-cell fluorescence microscopy. The time evolution
of the total number of cells and the percentage of cells
marked with PI are shown in Fig. 5.
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Figure 5: Live-cell fluorescence microscopy of GFP fu-
sion MDA-MB-231 marked with propidium iodide (PI).
(a) Number of cells marked with GFP as a function fo
time after plasma treatment in different conditions. (b)
Percentage of PI positive cells as a function of time after
plasma treatment for the different conditions. The con-
ditions are: Ω mode for 300 s, γ mode for 180 s, jet mode
for 25 s and gas control for 300 s. Error bars represent
the standard deviation on at least n = 3 independent
experiments.
The total number of cells after exposure to different
plasma treatments is shown in Fig. 5(a). In the control
group, the cell count increases exponentially, indicating
a normal proliferative capacity. However, all discharge
modes presented in Fig. 5(a) show a completely differ-
ent portrait than the control after a few days of incuba-
tion. The low total number of cells indicates that treated
cells exhibit an impaired proliferation (confirming the
results of Fig. 4). Fig. 5(b) presents the percentage
of cells marked with PI as a function of time after the
treatment. During the first day, almost no PI uptake
is observed, indicating that cell membranes are not di-
rectly damaged by plasma. After 48 h, the percentage of
PI-positive cells increases significantly for all discharge
modes. The percentage of PI-positive cells does not rise
above 60% because an important number of dead cells
eventually detach from the well plate and no longer count
as PI-positive.
Further insights in the cell death dynamics can be ob-
tained by following the evolution of single cells by live-cell
fluorescence microscopy. This is shown in Fig. 6 where a
few cells were monitored after a treatment of 120 s in the
γ mode. In the control case [Fig. 6(f) to (j)], cells have
Figure 6: Live-cell fluorescence microscopy of GFP fu-
sion MDA-MB-231 marked with propidium iodide (PI)
recorded at different times after treatment. In the γ
mode for 120 s at (a) 12 h, (b) 36 h, (c) 60 h, (d) 72 h
and (e) 132 h after the treatment. In the control group
at (f) 12 h, (g) 24 h, (h) 36 h, (i) 48 h and (j) 72 h.
a morphology typical of MDA-MB-231 and are prolifer-
ating normally. However, the cells that were exposed to
the plasma treatment exhibit a completely different dy-
namics. Early after the treatment [Fig. 6(a)], it is clear
that most cells are intact and morphologically similar to
those present in the control group. Between 24 h and
60 h, cells seem to be attempting to divide and their cy-
toplasm tends to shrink. Only a few cells exhibit a PI
uptake during this period. Finally, after 60 h most cells
are marked with PI and some show fragmentation, likely
a consequence of the formation of apoptotic bodies. It
is worthy of note that the behaviour observed for the γ
mode is representative of those observed using the Ω and
the jet modes (data not shown).
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Figure 7: Comet assay showing the DNA damages induced by plasma treatment. Example of comet assay after (a)
control, (b) treatment in the Ω mode, (c) positive control. (d) Standard box-and-whisker plot (box representing
lower quartile, median and upper quartile and whiskers representing one standard deviation below and above the
mean) of the percentage of DNA in the tail for all cells measured in the comet assay in each discharge mode
for a single experiment. (e) Mean of the percentage of DNA in the tail in different discharge mode for multiple
independent experiments (n = 4) with the error bars being the standard deviation. Treatments are performed in
the Ω mode for 300 s, in the γ mode for 180 s and in the jet mode for 25 s. Treatment times were chosen to give
similar anti-proliferative effect. Positive control is obtained by irradiation with 8 Gy. On average, about 75 cells
were considered in each condition. Statistical significance given by t-test with ***= p < 0.001.
4.3 Plasma-induced DNA damages
In order to identify potential DNA damages (mostly dou-
ble strand breaks [30]) by plasma treatments, a comet
assay was performed within 1 h of plasma exposure. The
results are shown in Fig. 7. Subfigures (a), (b) and (c)
display examples of comets for control (no treatment),
plasma treated (300 s of Ω mode) and positive control
(8 Gy). These images are typical of the neutral comet
assay, for which DNA migration tails are smaller than
for the alkaline comet assay [31]. In the control im-
age, almost 100% of the DNA is found to be located
in the comet head, while in the plasma and positive con-
trol cases, a significant portion of the DNA is found in
the comet tail. In agreement with previously reported
plasma cancer treatment experiments [32], the comet as-
say highlights the fact that plasma induces DNA dam-
ages to cancer cells.
Fig. 7(d) shows an example of a box-and-whisker plot
of the percentage of DNA in the tail for different dis-
charge modes after a single experiment. In this figure,
the baseline level of DNA damage (median of the per-
centage of the DNA in the tail) is between 10% and 15%
for the control and the gas flow control. This is typical
of cancer cells [33], as they already encompass a signif-
icant amount of baseline DNA damages. Fig. 7(d) also
shows that, for all conditions, the distribution of the per-
centage of DNA in the tail is defined by only one pop-
ulation (not necessarily normally distributed). Finally,
Fig. 7(e) shows the mean of the percentage of DNA in
the tail for four independent experiments (n = 4). It is
found that, using any plasma treatment, the percentage
of DNA in the tail reaches a level similar to the positive
control. In fact, no statistically significant difference is
observed between any discharge mode and positive con-
trol (8 Gy of radiation). In other words, for a given anti-
proliferative effect, all discharge modes can be considered
a DNA damaging agent.
4.4 Comparison of the treatment in sus-
pension with plasma treated medium
In this work, cells were exposed to plasma in the presence
of culture medium. As a consequence, the anti-cancer
effect of plasma could be secondary to indirect effects
from the interaction between the medium and plasma.
In other words, the anti-cancer effect of plasma might be
caused by:
1. direct interaction of the gas phase reactive species
with the cells and culture medium (through liquid
phase short-lived species such as OH, H, NO, etc.
[34]) or
2. long-lived liquid phase reactive species resulting
from conversion of short-lived species that accumu-
late in the culture medium over time (such as H2O2,
NO2, H2, etc. [35]).
In the first case, cells actually need to be in contact with
the gas phase eﬄuents, while in the second case, the
treatment is akin to an indirect treatment with PTM.
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To verify that the treatment of cancer cells in suspen-
sion presented above is different from the indirect effects
of PTM, a comparison of the two treatment methods is
performed. This comparison is achieved using the pro-
liferation assay (as in Fig. 4) with treatments for which
cells are present or absent from the microtubes during
plasma exposure. Results are shown in Fig. 8, where
cells in suspension are seeded in the 24-well plate with
20% of treated medium (same as for the previous sec-
tions) or untreated cells are seeded in the 24-well plate
with 20% or 80% of PTM.
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Figure 8: Comparison of treatment in suspension and
plasma treated medium using cell proliferation 6 d after
plasma treatment. The method and experimental condi-
tions are the same as in Fig. 4. The longest treatment
time was used for each discharge mode: 300 s in the Ω
mode, 180 s in the γ mode and 25 s in the jet mode.
Error bars represent the standard deviation on at least
n = 3 independent experiments. Statistical significance
given by t-test with *= p < 0.05, **= p < 0.01 and
***= p < 0.001.
First, whether the discharge is in the Ω, the γ or the
jet mode, no statistically significant difference is observed
between the control and the treatment of cells with 20%
of PTM (same concentration as for the direct treatment
of cells in suspension). As previously observed in Fig. 4,
the direct treatment of cells in suspension followed by a
proliferation assay (keeping 20% of the treated medium
with the cells) significantly decreases proliferation (90%
less than in the control). This clearly indicates that all
discharge modes have a direct impact on the cells’ pro-
liferative capacity and that the interaction of the cells
with the gas phase eﬄuents or short-lived liquid reactive
species is a necessary condition for this anti-proliferative
effect. Second, Fig. 8 indicates that 80% of PTM is
enough to significantly affect the proliferative capacity of
the cells. In fact, cell proliferation undergoes a decrease
as important as for the treatment in suspension in both
Ω and γ modes for a treatment with 80% of PTM. This
suggests that, in sufficient concentration, long-lived re-
active species can also lead to an anti-proliferative effect.
Accumulation of H2O2 in the medium is not expected to
contribute to the treatment, as it is always below detec-
tion level (about 1 µM, data not shown). In addition,
no variation of pH (< 0.1) of the medium was observed
after any treatment with respect to the control.
5 Discussion
While plasma treatment of cancer cells in suspension is
usually not the preferred application method, it is an effi-
cient model to compare the anti-cancer effect of different
types of plasmas or discharge modes [18, 36]. In terms
of anti-proliferative effect, the results shown above are in
good agreement with other treatments by plasma in sus-
pension in the literature [18, 37, 38]. On the one hand,
using the eﬄuents of the Ω mode requires a treatment
time of several minutes to produce its anti-proliferative
effect. This is in agreement with its plasma properties
that resemble those of the COST plasma jet [18, 12, 39].
On the other hand, treating cells in suspension with the
eﬄuent of the jet mode only requires a few seconds to
yield the same anti-proliferative effect. In that case, the
plasma properties are much closer to those of the kIN-
Pen plasma jet [36, 38]. Even if the COST and kINPen
devices are the most often used for plasma medical appli-
cations, they have very different plasma properties. One
of the most basic parameters that differ significantly be-
tween these plasma jets is the electron energy [12, 23].
Electron energy is one of the most fundamental param-
eters that can drive the production of RONS, hence in-
fluencing the anti-cancer effect of plasma.
From the set of data presented in Fig. 4 and the he-
lium line ratios given in table 2, it is possible to correlate
the electron energy with the efficacy of the treatment.
This is shown in Fig. 9, where the anti-proliferative ef-
fect of the plasma is given as a function of the mean of
the normalized helium line ratios. As reported in table
2, the electron energy (assuming the electron energy is
proportional to the helium line ratios) increases from the
Ω to the γ to the jet modes. Normalizing each line ra-
tio to their value in the jet mode, a good agreement is
found between the line ratios and the time to reach the
maximum anti-proliferative capacity. This supports the
fact that a plasma with higher electron energy is more
efficient to produce RONS that can yield an efficient anti-
cancer treatment.
As shown in Fig. 7, all discharge modes were able to
induce DNA damages to MDA-MB-231. As the comet
assay was performed about 1 h after treatment, some of
the observed DNA damages could eventually be repaired
over the course of time. Accordingly, the extent of the
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Figure 9: Correlation between the mean of the normal-
ized helium line ratios (values from table 2 normalized
to the jet mode value for each ratio) and the treatment
time to reach the maximum anti-proliferative effect. Er-
ror bars represent the standard deviation over the two
line ratios. Statistical significance given by a one-way
ANOVA with p < 0.05.
observed DNA damages cannot be directly linked to the
fate of the cells. However, the amount of DNA dam-
ages measured by the neutral comet assay immediately
after exposure to radiation therapy can be considered as
a relative indicator of radiosensitivity [40]. In our exper-
iment, the same amount of DNA damages is observed
using any discharge mode (at a dose for which prolifer-
ation is similarly affected) or positive control (8 Gy of
radiation therapy). Despite the generally accepted dif-
ference in the underlying physical mechanisms leading to
cell death by plasma and radiation therapy (exogenous
production of extracellular vs. intracellular RONS [41]),
in the present experimental setup, it is possible that ir-
radiation of cells in suspension with high energy photons
(Caesium-137) relies on the same mechanisms as plasma
treatment. As most of the irradiated volume (> 99%)
is occupied by culture medium, the principal effect of
radiation therapy might be related to radiation energy
deposited within the liquid (as opposed to within cells).
Via the detachment of low energy secondary electrons
[42], irradiation could lead to the production of extra-
cellular RONS in the medium that eventually penetrate
cells to produce a cytotoxic effect. In such a situation,
both plasma and radiation therapy would rely on the
production of extracellular RONS.
Comparing the treatment of MDA-MB-231 cells in sus-
pension with PTM, Fig. 8 showed that direct treatment
is much more cytotoxic than PTM. This could be ex-
plained by the very low concentration of H2O2 observed
in the treated medium (< 1 µM). H2O2 is likely rapidly
scavenged by pyruvate in the culture medium [43, 44, 45],
disabling it from having any long-term effect on the cells.
Since H2O2 is considered one of the main plasma de-
rived components causing biological effects [35], it can
be expected that, whether applied directly or indirectly,
plasma should yield similar cytotoxic effect when H2O2 is
allowed to accumulate in the medium containing the cells
[46, 47]. As in the present work direct plasma and PTM
have very different cytotoxicity, a more complex dynamic
of the RONS interaction with the cells is expected. An-
other interesting feature of Fig. 8 is that PTM produced
by the jet mode is less efficient at reducing cell prolifer-
ation than the PTM produced by the γ and Ω modes.
This highlights the potential variability between the dif-
ferent discharge modes. This feature suggests that the
jet mode is more efficient at producing short-lived reac-
tive species, while the Ω and γ modes are more efficient
at producing long-lived reactive species. These elements
could be correlated to the treatment time, that is much
longer with the latter modes than with the jet mode.
Even if the nature of cell death is a complex matter
to settle, the facts that (1) plasma treatment immedi-
ately affects cell proliferation (Fig. 4), and that (2) cells
are gradually driven to undergo cell death (Fig. 5 and
Fig. 6), strongly indicate a form of regulated cell death
(RCD). In addition, observation of significant DNA dam-
ages shortly after treatment (Fig. 7) suggests that the
dominant form of RDC could be mitotic death [48]. A
possible mechanism would be that plasma treatment ini-
tially causes mitotic catastrophe. Then, although very
low concentration of H2O2 is detected in our conditions
(one of the RONS often recognized to lead to apoptosis in
other plasma treatments [49]), low concentration of long-
lived reactive species could be sufficient to induce mitotic
death through intrinsic apoptosis. It is also possible that,
due to the complex combination of extracellular RONS
produced by the plasma [50, 51], more than one form of
RCD occurs after plasma exposure. Further investigation
is needed to clarify the ongoing form of RCD induced by
our plasma treatments and method.
6 Conclusion
A convertible plasma jet device was designed to produce
three different discharge modes. Feeding the device with
a 13.56 MHz radio-frequency excitation waveform and
helium gas flow, the Ω and γ modes of the atmospheric-
pressure CCRF discharge were obtained. Additionally,
a RF plasma jet could also be obtained only by chang-
ing the helium injection pattern. The cytotoxicity of the
three discharge modes was then investigated on MDA-
MB-231 triple negative breast cancer cell line. Treat-
ments were performed with cells in suspension within
DMEM culture medium, and only the gas phase eﬄu-
ent was put in contact with the cell-containing culture
medium. The treatment time of the different discharge
modes to reach the same anti-proliferative effect was
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found to vary significantly from one mode to the other,
the jet mode requiring less than one tenth of the time re-
quired in the Ω and γ modes. The efficacy (time required
to reach the same cytotoxic effect) of the discharge mode
was found to be correlated with the electron energy of the
plasma. Using a treatment time that leads to an equiva-
lent anti-proliferative effect in each discharge mode was
also found to induce a similar dynamic of cell death and
an equivalent quantity of DNA damages, suggesting that
all discharge mode lead to a similar form of regulated cell
death. Finally, as the cytotoxicity of direct plasma treat-
ment was found to be different from the one of plasma
treated medium, the mechanism leading to cell death is
expected to rely on the gas phase or liquid phase short-
lived RONS. Further investigations need to be performed
to clarify the nature of the cell behaviour and death after
plasma exposure.
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